| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2023 | NATIONAL PSORIASIS | 1800 DIAGONAL RD | ALEXANDRIA | VA | 22314-2842 | ALEXANDRIA CITY | USA | NU58DP007060 | Improving Patient Outcomes through Increased Awareness of Psoriasis as a Chronic Immune-mediated Systemic Inflammatory Disease | 01 | 3 | CDC | 4/18/2025 | $0 |
| | 2025 | 2022 | NATIONAL PSORIASIS | 1800 DIAGONAL RD | ALEXANDRIA | VA | 22314-2842 | ALEXANDRIA CITY | USA | NU58DP007060 | Improving Patient Outcomes through Increased Awareness of Psoriasis as a Chronic Immune-mediated Systemic Inflammatory Disease | 01 | 3 | CDC | 4/18/2025 | $0 |
| | 2025 | 2021 | NATIONAL PSORIASIS | 1800 DIAGONAL RD | ALEXANDRIA | VA | 22314-2842 | ALEXANDRIA CITY | USA | NU58DP007060 | Improving Patient Outcomes through Increased Awareness of Psoriasis as a Chronic Immune-mediated Systemic Inflammatory Disease | 01 | 3 | CDC | 4/18/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $375,000 ) |
| | 2024 | 2024 | NATIONAL PSORIASIS | 1800 DIAGONAL RD | ALEXANDRIA | VA | 22314-2842 | ALEXANDRIA CITY | USA | NU58DP007836 | Increasing Awareness of Psoriasis as a Chronic Immune-Mediated Systemic Inflammatory Disease to Improve Patient Outcomes | 00 | 1 | CDC | 8/6/2024 | $375,000 |
| | 2024 | 2024 | NATIONAL PSORIASIS | 1800 DIAGONAL RD | ALEXANDRIA | VA | 22314-2842 | ALEXANDRIA CITY | USA | NU58DP007836 | Increasing Awareness of Psoriasis as a Chronic Immune-Mediated Systemic Inflammatory Disease to Improve Patient Outcomes | 01 | 1 | CDC | 9/17/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $351,404 ) |
| | 2023 | 2023 | NATIONAL PSORIASIS FOUNDATION | 6600 SW 92nd Ave Ste 300 | Portland | OR | 97223-7195 | WASHINGTON | USA | NU58DP007060 | Improving Patient Outcomes through Increased Awareness of Psoriasis as a Chronic Immune-mediated Systemic Inflammatory Disease | 00 | 3 | CDC | 6/30/2023 | $351,404 |
| | 2023 | 2022 | NATIONAL PSORIASIS FOUNDATION | 6600 SW 92nd Ave Ste 300 | Portland | OR | 97223-7195 | WASHINGTON | USA | NU58DP007060 | Improving Patient Outcomes through Increased Awareness of Psoriasis as a Chronic Immune-mediated Systemic Inflammatory Disease | 00 | 3 | CDC | 6/30/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $351,404 ) |
| | 2022 | 2022 | National Psoriasis Foundation | 6600 Sw 92nd Ave Ste 300 | Portland | OR | 97223-7195 | WASHINGTON | USA | NU58DP007060 | Improving Patient Outcomes through Increased Awareness of Psoriasis as a Chronic Immune-mediated Systemic Inflammatory Disease | 00 | 2 | CDC | 7/12/2022 | $351,404 |
| | 2022 | 2021 | National Psoriasis Foundation | 6600 Sw 92nd Ave Ste 300 | Portland | OR | 97223-7195 | WASHINGTON | USA | NU58DP007060 | Improving Patient Outcomes through Increased Awareness of Psoriasis as a Chronic Immune-mediated Systemic Inflammatory Disease | 01 | 1 | CDC | 10/13/2021 | $0 |
| | 2022 | 2021 | National Psoriasis Foundation | 6600 Sw 92nd Ave Ste 300 | Portland | OR | 97223-7195 | WASHINGTON | USA | NU58DP007060 | Improving Patient Outcomes through Increased Awareness of Psoriasis as a Chronic Immune-mediated Systemic Inflammatory Disease | 02 | 1 | CDC | 1/27/2022 | $0 |
| | 2022 | 2017 | NATIONAL PSORIASIS FOUNDATION | 6600 SW 92ND AVE STE 300 | PORTLAND | OR | 97223-7195 | WASHINGTON | USA | R13AR072521 | 2017 National Psoriasis Foundation Research Symposium | 000 | 1 | NIH | 10/21/2021 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $326,934 ) |
| | 2021 | 2021 | National Psoriasis Foundation | 6600 SW 92nd Ave Ste 300 | Portland | OR | 97223-7195 | WASHINGTON | USA | NU58DP007060 | Improving Patient Outcomes through Increased Awareness of Psoriasis as a Chronic Immune-mediated Systemic Inflammatory Disease | 00 | 1 | CDC | 8/17/2021 | $326,934 |
|
| Issue Date FY: 2017 ( Subtotal = $20,000 ) |
| | 2017 | 2017 | NATIONAL PSORIASIS FOUNDATION | 6600 SW 92ND AVE STE 300 | PORTLAND | OR | 97223-7195 | WASHINGTON | USA | R13AR072521 | 2017 National Psoriasis Foundation Research Symposium | 000 | 1 | NIH | 8/3/2017 | $20,000 |
|
|
